Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 310.00
Bid: 307.00
Ask: 312.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.629%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 310.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: STV looks to summer's football; In The Style sales up

Thu, 29th Apr 2021 14:34

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

STV Group PLC - Glasgow-based television broadcaster - Says recovery of advertising revenue exceeds expectations, running 10% ahead of forecasts. "STV-controlled advertising continues to outperform the wider market, with regional advertising revenues up 12% in the first four months of the year," company adds. Video on demand service advertising also grew, up 26% annually and posts eight successive months of growth. Online viewing grew 73% in first quarter. Expects viewing figures in June as delayed Euro 2020 football championships kick off.

----------

In The Style Group PLC - e-commerce womenswear fashion brand - Says sales momentum since March float top expectations. Revenue for year ended March 31 to soar to GBP44.5 million from GBP19.3 million. "In light of the strong trading performance, prior to the year end the group returned financial support previously claimed under the Coronavirus Job Retention Scheme," company adds.

----------

Inspecs Group PLC - eyewear design house and manufacturer based in Bath - Says first quarter revenue amounted to USD67 million. "This performance was achieved despite nationwide lockdowns in the UK, Germany and France and a variety of state lockdowns in the USA," Inspecs says. "Whilst this performance marks a positive start to the year, the board remains cautious on 2021 as Covid-19 remains prevalent across the world."

----------

Appreciate Group PLC - Liverpool-based multi-retailer - Pretax profit for year ended March 31 in line with market expectations range of GBP4.1 million an GBP4.8 million. Group billings down 3.2% to GBP406.5 million from GBP419.9 million.

----------

City Pub Group PLC - operates 48 pubs in southern England and Wales - Acquires 49% stake in Barts Pub Ltd, owner of Kensington Park Hotel in London's Ladbroke Grove, for GBP750,000. "It has large trading areas on the ground and first floors, benefits from seven hotel letting rooms and has potential for a further four letting rooms on the top floor. Ladbroke Grove is a prime residential area in London and the Company trades very successfully at the Cock & Bottle, Notting Hill, which is located close by," City Pub says. Increases stake in Mosaic Pub & Dining Group to 24% for GBP1.2 million. "The company acquired a 14% stake in the Mosaic Companies in September 2020 and this transaction takes its total investment to GBP2.4 million," company adds. Mosaic owns nine "prominent pubs" and largely operates in London and Birmingham.

----------

Arricano Real Estate PLC - developer and shopping mall operator in Ukraine - In separate announcements notes the easing of restrictions in Ukraine and an altered loan facility in country. Says Kiev retail shopping centres to reopen on May 1 but says its City Mall in Zaporizhzhia closed until further notice. Also says unit LLC Comfort Market Luks alters debt arrangement with State Savings Bank of Ukraine. Debt now carries 6.5% annual interest, down from 7.5%.

-----------

Symphony International Holdings Ltd - Hong Kong-based investor - Asset Value Investors, which holds 15% stake in Symphony, takes aim at management of investment firm. Pens note to shareholders labelled "Save Symphony". "The poor performance of Symphony International Holdings Ltd has gone on long enough. We have two key aims and we need the support of our fellow shareholders to make them a reality," Asset Value Executive Director Tom Treanor says. Company wants to gather enough support to requisition extraordinary general meeting to replace directors. Also wants all shareholders to be "fully informed as to our concerns regarding the stewardship of SIHL and the independence of the board".

----------

LMS Capital PLC - London-based investment firm - Net asset value at end of first quarter slips 0.8% to 58.9 pence per share from 59.4p at end of December. Sees GBP300,000 unrealised gains on investment portfolio, but GBP200,000 million foreign exchange hit and GBP500,000 of running and investment costs.

----------

FastForward Innovations Ltd - investor in life sciences and technology businesses particularly within the medical cannabis field - Says 5.1%-owned Yooma Wellness Inc's CBD food products from its MYO Plant Nutrition and Blossom brands added to UK Food Standard Agency's novel foods list. "This approval represents a significant milestone for the MYO and Blossom brands," Yooma Chair Lorne Abony says.

----------

Hutchison China Meditech Ltd - Hong-Kong-based pharmaceutical company - Initiates registration-intent Phase II clinical trial of HMPL‑689, a PI3Ko inhibitor and can be used to treat forms of cancer. Trial focused on patients with relapsed or refractory follicular lymphoma and marginal zone lymphoma. On Wednesday, shareholders backed company's name change to Hutchmed (China) Ltd. Name change effective only Registrar of Companies issues certificate.

----------

Verici Dx PLC - clinical diagnostics developer for organ transplant - Signs lease in Tennessee, US for site it plans to use as Clinical Laboratory Improvement Amendments-certified laboratory. "I joined the company in January this year to help expedite the CLIA approval strategy and signing the lease to this space marks the first step towards achieving these CLIA approvals necessary for commercial launch of the company's leading products, Clarava and Tuteva," Vice President of Quality & Regulatory Affairs David Schultenover says.

----------

InnovaDerma PLC - London-based developer of beauty, personal care and life science products - Raises GBP500,000 from open offer, taking total fundraising to GBP4.5 million. Non-Executive Chair Ross Andrews says "macroeconomic environment is set to remain uncertain" this financial year but notes UK vaccinations and government lockdown easing roadmap going according to plan. "We've just entered the peak tanning season and the exact speed of a return to historical consumption levels will only be known over the coming months," Andrews adds.

----------

Yourgene Health PLC - Manchester, England-headquartered molecular diagnostics firm - Says revenue for year ended March 31 to rise 10% to GBP18.3 million from GBP16.6 million. "This is in line with recently issued guidance and reflects strong performances for European core revenues and for Covid-related testing products and services focused on the UK, more than offsetting the pandemic headwinds affecting international sales," Yourgene adds.

----------

Silence Therapeutics PLC - novel RNA therapeutics developer with offices in London and Berlin - Says first patient dosed in Gemini Phase I clinical trial of SLN124, a treatment for a rare pediatric disease. "Today's announcement is an exciting milestone in the development of SLN124. It is the result of many years of hard work," Chief Medical Officer Giles Campion says.

----------

Danakali Ltd - Colluli potash project developer - Raises AUD20.3 million, to fund work at Colluli asset, Eritrea. Says early works programme will begin "immediately".

----------

Greatland Gold PLC - precious and base metals exploration and development in Western Australia and Tasmania - Notes Newcrest Mining Ltd's quarterly update which refers to progress at Havieron gold asset. Says new assay results show four holes intersect "significant mineralisation". Results from wider growth drilling "continue to support the potential for resource expansion of the Havieron".

----------

Salt Lake Potash Ltd - Western Australia focused organic sulphate of potash miner - Receives new portion of environmental approval for Lake Way project. Says permit enables firm to construct pond trains 4-6. "Receiving final environmental approval over the full Lake Way project will enable our team to commence construction of the remaining on-lake infrastructure and deliver the full scope of the Lake Way project. We look forward to commencing work shortly on this final phase," Chief Executive Officer Tony Swiericzuk says.

----------

Ariana Resources PLC - exploration and development company operating in Europe - Reports promising findings from drilling results at Arzu North portion of Kiziltepe mine in Turkey. Says over 450 metres of "potentially open-pittable extensions confirmed". Adds that revised JORC exploration target now includes addition 7,000 ounces to 25,000 ounces of gold and 150,000 ounces to 250,000 ounces of silver, representing a more than four-fold resource hike. "This is an excellent set of results from the recent drilling at Arzu North. Collectively these results confirm the potential to extend the Arzu North open pit both to the northwest and to the southeast," Managing Director Kerim Sener says.

----------

Condor Gold PLC - gold exploration and development in Nicaragua - Says all infill drilling and assay at La India starter pits completed. "The drilling results received to date support, and add considerable confidence to, the geological model," Condor Gold says. Drilling underway for remaining 1,142 metres of work in La India open pit shell.

----------

Horizonte Minerals PLC - nickel company focused on Brazil - Hands environmental & social impact assessment at Vermelho nickel and cobalt project to consultancy firm Ramboll. "Ramboll's Impact Assessment services are based on both commercial understanding and technical rigour to deliver projects that are advanced, sustainable and provide value to society. Horizonte has previously worked with Ramboll on the hydrology for its flagship Araguaia ferronickel project," Horizonte adds.

----------

Gaming Realms PLC - London-based mobile games developer - Begins trading on OTCQX Best Market in US. "Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their US investors," company notes.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 Aug 2023 09:30

IN BRIEF: China grants Hutchmed's savolitinib breakthrough therapy tag

Hutchmed (China) Ltd - Hong Kong-based developer of treatments for cancer and immunological diseases - Wins 'breakthrough therapy designation' in China for its gastric cancer treatment, savolitinib. The BTD is granted by the National Medical Products Administration. It is for the treatment of locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma patients with mesenchymal epithelial transition factor amplification who have failed at least two lines of standard therapies. Hutchmed notes that MET-driven gastric cancer has a poor prognosis, and China grants a BTD to new drugs that treat life-threatening diseases for which there are no effective treatment options.

Read more
21 Aug 2023 08:46

Hutchmed China hails trial on sovleplenib meeting primary endpoint

(Alliance News) - Hutchmed (China) Ltd on Monday said a phase 3 trial evaluating the investigational use of sovleplenib met its primary endpoint.

Read more
21 Aug 2023 08:24

Hutchmed meets all endpoints in platelet disorder treatment trial

(Sharecast News) - Hutchmed China reported a breakthrough from its recent phase three trial in sovleplenib on Monday, reporting that it met its primary endpoint and all secondary endpoints for treating adult patients with primary immune thrombocytopenia - a platelet disorder - (ITP) in China.

Read more
31 Jul 2023 12:47

Hutchmed swings to profit after "sharpening goals and priorities"

(Alliance News) - Hutchmed (China) Ltd on Monday reported sharp first-half revenue growth, as a strategy change to boost its fortunes outside of China saw early fruit.

Read more
24 Jul 2023 15:46

UK earnings, trading statements calendar - next 7 days

Tuesday 25 July 
City of London Investment Group PLCTrading Statement
Compass Group PLCTrading Statement
Croda International PLCHalf Year Results
Games Workshop Group PLCFull Year Results
Greencore Group PLCTrading Statement
Hummingbird Resources PLCTrading Statement
MITIE Group PLCTrading Statement
Paragon Banking Group PLCTrading Statement
Reach PLCHalf Year Results
Smart Metering Systems PLCTrading Statement
Tristel PLCTrading Statement
Tyman PLCHalf Year Results
Unilever PLCHalf Year Results
Unite Group PLCHalf Year Results
Wednesday 26 July 
Aptitude Software Group PLCHalf Year Results
Breedon Group PLCHalf Year Results
Conduit Holdings LtdHalf Year Results
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
FRP Advisory Group PLCFull Year Results
Gresham Technologies PLCHalf Year Results
Lloyds Banking Group PLCHalf Year Results
Marston's PLCTrading Statement
Nichols PLCHalf Year Results
Primary Health Properties PLCHalf Year Results
Rathbones Group PLCHalf Year Results
Revolution Bars Group PLCTrading Statement
Rio Tinto PLCHalf Year Results
Science Group PLCHalf Year Results
Van Elle Holdings PLCFull Year Results
Thursday 27 July 
Allianz Technology Trust PLCHalf Year Results
Antofagasta PLCHalf Year Results
Capital & Regional PLCHalf Year Results
Card Factory PLCTrading Statement
Checkit PLCTrading Statement
Drax Group PLCHalf Year Results
Deliveroo PLCHalf Year Results
Derwent London PLCHalf Year Results
Entain PLCHalf Year Results
Greencoat UK Wind PLCHalf Year Results
Global Connectivity PLCHalf Year Results
Hostelworld Group PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Lancashire Holdings LtdHalf Year Results
Mitchells & Butlers PLCTrading Statement
OSB Group PLCHalf Year Results
Persimmon PLCHalf Year Results
Petrofac LtdHalf Year Results
Redcentric PLCFull Year Results
S&U PLCTrading Statement
Savills PLCHalf Year Results
Secure Trust Bank PLCHalf Year Results
Spirax-Sarco Engineering PLCHalf Year Results
Videndum PLCHalf Year Results
Wheaton Precious Metals CorpHalf Year Results
Friday 28 July 
AIB Group PLCHalf Year Results
GCP Infrastructure Investments LtdTrading Statement
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Jardine Matheson Holdings LtdHalf Year Results
NatWest Group PLCHalf Year Results
PayPoint PLCFull Year Results
PayPoint PLCTrading Statement
Standard Chartered PLCHalf Year Results
YouGov PLCTrading Statement
Monday 31 July 
Hutchmed (China) LtdHalf Year Results
Pearson PLCHalf Year Results
Pod Point Group Holdings PLCHalf Year Results
Quartix Technologies PLCHalf Year Results
Spectris PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
20 Jul 2023 14:14

IN BRIEF: Hutchmed progresses fruquintinib designation and testing

Hutchmed (China) Ltd - Hong Kong-based developer of treatments for cancer and immunological diseases - Granted breakthrough therapy designation, by the Center for Drug Evaluation of China's National Medical Products Administration, for oral inhibitor fruquintinib combined with PD-1 antibody sintilimab. BTD is for treatment of patients with previously treated advanced endometrial cancer.

Read more
10 Jul 2023 12:58

Hutchmed launches new phase one study in China

(Sharecast News) - Biopharmaceutical company Hutchmed China announced the launch of a phase one study in China for HMPL-415 on Monday - an investigational selective allosteric inhibitor that targeted Src homology-2 domain-containing protein tyrosine phosphatase-2 (SHP2).

Read more
10 Jul 2023 08:53

IN BRIEF: Hutchmed starts study for tumour treatment in China

Hutchmed (China) Ltd - Hong Kong-based cancer and immunological diseases' treatment developer - Starts phase one study in China of its SHP2 inhibitor HMPL-415 for the treatment of advanced malignant solid tumours. First patient received their first dose on Thursday last week. Hutchmed expects up to 80 patients to take part in the study. SHP2 is a non-receptor protein tyrosine phosphatase which controls cell growth and cell migration.

Read more
16 Jun 2023 08:51

Hutchmed, Takeda Fresco-2 study published in The Lancet

(Alliance News) - Hutchmed (China) Ltd on Friday said phase three results for its Fresco-2 study evaluating fruquintinib in patients with previously treated metastatic colorectal cancer, conducted alongside Takeda Pharmaceutical Co Ltd, were published in peer-reviewed journal, The Lancet.

Read more
16 Jun 2023 08:44

Hutchmed China's colorectal cancer study to be published

(Sharecast News) - Hutchmed China, alongside its partner Takeda, announced the publication of the phase three 'FRESCO-2' study results evaluating the use of fruquintinib in patients with previously-treated metastatic colorectal cancer (CRC) on Friday, in the Lancet medical journal.

Read more
15 Jun 2023 16:51

IN BRIEF: Hutchmed and Takeda get Europe marketing backing for drug

Hutchmed (China) Ltd - Hong Kong-based cancer and immunological diseases treatment developer - Says marketing authorisation application for fruquintinib, made alongside Tokyo-based Takeda Pharmaceutical Co Ltd, has been validated and caccepted by the European Medicines Agency. Fruquintinib is an inhibitor of vascular endothelial growth factor receptors used to treat cancers.

Read more
26 May 2023 13:13

US FDA gives priority to Hutchmed's colorectal cancer treatment

(Sharecast News) - Hutchmed China, in collaboration with Takeda, announced on Friday that the US Food and Drug Administration (FDA) has granted priority review for the New Drug Application (NDA) of fruquintinib.

Read more
26 May 2023 08:56

Hutchmed China celebrates FDA review, teases new data at ASCO meeting

(Alliance News) - Hutchmed China Ltd on Friday celebrated a priority review granted by the US FDA for its cancer drug fruquintinib, and promised to present new data for this and two other therapies at the American Society of Clinical Oncology next month.

Read more
5 May 2023 15:57

UK shareholder meetings calendar - next 7 days

Monday 8 May 
no events scheduled 
Tuesday 9 May 
Caledonia Mining Corp PLCAGM
Direct Line Insurance Group PLCAGM
Foxtons Group PLCAGM
Hostelworld Group PLCAGM
IWG PLCAGM
Just Group PLCAGM
Midwich Group PLCAGM
Osirium Technologies PLCAGM
Windward LtdAGM
Wednesday 10 May 
abrdn PLCAGM
Antofagasta PLCAGM
Cenkos Securities PLCAGM
Ecora Resources PLCAGM
H&T Group PLCAGM
Harbour Energy PLCAGM
Jupiter Fund Management PLCAGM
Literacy Capital PLCAGM
Luceco PLCAGM
Marshalls PLCAGM
National Express Group PLCAGM
Renewables Infrastructure Group LtdAGM
Rentokil Initial PLCAGM
Seplat Energy PLCAGM
Spirax-Sarco Engineering PLCAGM
TClarke PLCAGM
Thursday 11 May 
88 Energy LtdAGM
Cairn Homes PLCAGM
Capita PLCAGM
Clarkson PLCAGM
Costain Group PLCAGM
Eleco PLCAGM
Eurocell PLCAGM
FBD Holdings PLCAGM
Genedrive PLCGM re Equity Prepayment Facility
Genel Energy PLCAGM
Gresham House PLCAGM
Gym Group PLCAGM
Hiscox LtdAGM
Irish Continental Group PLCAGM
John Wood Group PLCAGM
MyHealthChecked PLCAGM
OSB Group PLCAGM
Poolbeg Pharma PLCAGM
Rolls-Royce Holdings PLCAGM
Serinus Energy PLCAGM
Uniphar PLCAGM
Videndum PLCAGM
WAG Payment Solutions PLCAGM
Friday 12 May 
Balfour Beatty PLCAGM
Derwent London PLCAGM
Goodbody Health LtdAGM
GreenRoc Mining PLCAGM
Hutchmed (China) LtdAGM
Itim Group PLCAGM
Itsarm PLCGM re delisting from AIM
Wheaton Precious Metals CorpAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
18 Apr 2023 12:30

Hutchmed's gastric cancer treatment accepted for review in China

(Sharecast News) - Hutchmed China announced on Tuesday that its new drug application (NDA) for fruquintinib, in combination with paclitaxel has been accepted for review by the National Medical Products Administration (NMPA) in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.